tris[2-(2-hydroxyethoxy)ethyl]-octadecylazanium;phosphate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磷酸及其衍生物
• 英文名称: tris[2-(2-hydroxyethoxy)ethyl]-octadecylazanium;phosphate
• 化学式: C30H64NO10P-2
• 分子量: 629.8
• InChiKey: GUIWIPNQQLZJIE-UHFFFAOYSA-K

计算性质

• 辛醇/水分配系数(LogP)：
  2.27
• 重原子数：
  42
• 可旋转键数：
  32
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  175
• 氢给体数：
  3
• 氢受体数：
  10

ADMET

代谢

亚硝胺可以通过摄入、吸入或皮肤接触进入人体。一旦进入人体，亚硝胺会被细胞色素P-450酶代谢，这实际上会将它们激活成致癌物质。

Nitrosamines can enter the body via ingestion, inhalation, or dermal contact. Once in the body, nitrosamines are metabolized by cytochrome P-450 enzymes, which essentially activates them into carcinogens. (A2878, A2879)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 毒性总结

虽然四价铂-52本身并不具有毒性，但它是一种亚硝化剂。亚硝化剂可能会分解和/或反应导致亚硝胺污染。亚硝胺是在亚硝酸盐离子存在的情况下，由二级胺和酰胺产生的，被认为是致癌物质。一旦进入人体，亚硝胺会被细胞色素P-450酶激活。它们随后被认为通过在氮和氧原子上形成DNA加合物来诱导其致癌效应。(L1889, L1890, A2878, A2879, A2880)

While quaternium-52 itself is not toxic, it is a nitrosating agent. Nitrosating agents may decompose and/or react to cause nitrosamine contamination. Nitrosamines are produced from secondary amines and amides in the presence of nitrite ions and are believed to be carcinogenic. Once in the body, nitrosamines are activated by cytochrome P-450 enzymes. They are then believed to induce their carcinogenic effects by forming DNA adducts at the N- and O-atoms. (L1889, L1890, A2878, A2879, A2880)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 致癌物分类

未列入国际癌症研究机构(IARC)名录。某些亚硝胺被IARC分类为对人类可能是或可能具有致癌性（分别为2A组和2B组）。

Not listed by IARC. Certain nitrosamines are classified by IARC as either probably or possibly carcinogenic to humans (Groups 2A and 2B, respectively). (L135)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 健康影响

季铵盐-52可能会反应生成被认为具有致癌性的亚硝胺。(L1890)

Quaternium-52 may react to produce nitrosamines, which are believed to be carcinogenic. (L1890)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 暴露途径

口服（A2880）；吸入（A2880）；皮肤给药（L1889）

Oral (A2880) ; inhalation (A2880) ; dermal (L1889)

来源:Toxin and Toxin Target Database (T3DB)

文献信息

• Unmasking endotoxins in solution
  申请人：Hyglos Invest GmbH

  公开号：EP2955518A1

  公开（公告）日：2015-12-16

  The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.

  本发明涉及揭开组合物中内毒素的面纱，使以前存在但无法检测到的内毒素变得可以检测到。
• UNMASKING ENDOTOXINS IN SOLUTION
  申请人：bioMérieux Deutschland GmbH

  公开号：EP3155422B2

  公开（公告）日：2022-01-26
• [EN] UNMASKING ENDOTOXINS IN SOLUTION<br/>[FR] ENDOTOXINES DE DÉMASQUAGE EN SOLUTION
  申请人：MICROCOAT BIOTECHNOLOGIE GMBH

  公开号：WO2015189378A1

  公开（公告）日：2015-12-17

  The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.
• [EN] UNMASKING ENDOTOXINS IN SOLUTION<br/>[FR] DÉMASQUAGE D'ENDOTOXINES EN SOLUTION
  申请人：HYGLOS INVEST GMBH

  公开号：WO2015189379A1

  公开（公告）日：2015-12-17

  The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.